Hoffman Robert E. reported grant involving 79,873 shares of Esperion Therapeutics, Inc. at $0.00 for $0 on May 28, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Jun 1, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
79,873Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
85,153Direct
Trade date
May 28, 2026Grant
Filed
Jun 1, 2026, 4:23 PM ET4-day reporting delay
Accession
0001628280-26-039525Code A · Transaction 388459
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

ESPR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ESPR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −39%1w ago 0%1d ago 0%
Returns since7d +0.6%30d +1%90d +1.6%180d1y

Footnotes in full

F1: The awards vest in full on the earlier of (i) May 28, 2027 and (ii) the Issuer's next annual meeting of stockholders following May 28, 2026.